RVTY
Revvity Inc.

781
Mkt Cap
$10.46B
Volume
555,399.00
52W High
$128.29
52W Low
$81.36
PE Ratio
46.13
RVTY Fundamentals
Price
$93.79
Prev Close
$92.25
Open
$93.19
50D MA
$90.94
Beta
1.01
Avg. Volume
1.32M
EPS (Annual)
$2.41
P/B
1.43
Rev/Employee
$250,456.91
Loading...
Loading...
News
all
press releases
Geode Capital Management LLC Lowers Position in Revvity Inc. $RVTY
Geode Capital Management LLC decreased its position in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 0.6% during the second quarter, according to its most recent 13F filing with the Securities...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Envestnet Asset Management Inc. Trims Holdings in Revvity Inc. $RVTY
Envestnet Asset Management Inc. decreased its position in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 7.5% during the second quarter, according to the company in its most recent filing with...
MarketBeat·4d ago
News Placeholder
Mitsubishi UFJ Asset Management Co. Ltd. Sells 3,220,907 Shares of Revvity Inc. $RVTY
Mitsubishi UFJ Asset Management Co. Ltd. cut its position in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 93.5% in the second quarter, according to the company in its most recent filing with...
MarketBeat·7d ago
News Placeholder
Aviva PLC Purchases 4,303 Shares of Revvity Inc. $RVTY
Aviva PLC boosted its position in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 5.0% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund...
MarketBeat·7d ago
News Placeholder
Revvity Inc. (NYSE:RVTY) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of Revvity Inc. (NYSE:RVTY - Get Free Report) have received an average recommendation of "Moderate Buy" from the fourteen analysts that are covering the company, Marketbeat Ratings reports...
MarketBeat·10d ago
News Placeholder
Revvity To Acquire ACD/Labs For Undisclosed Sum
(RTTNews) - Revvity, Inc. (RVTY), a diagnostic and health sciences company, Monday announced that it has entered into a definitive agreement to acquire ACD/Labs, a provider of scientific software...
Nasdaq News: Markets·10d ago
News Placeholder
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
Revvity, Inc. (NYSE: RVTY), today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization...
Business Wire·10d ago
News Placeholder
Revvity to Present at Upcoming Investor Conferences
Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences: UBS Global Healthcare Conference 2025 Monday, November 10, 2025 8:00 a.m. ET - Max Krakowiak, senior...
Business Wire·23d ago
News Placeholder
Company News for Oct 28, 2025
Companies In The News Are: ARLP, DQ, KDP, RVTY.
Zacks·23d ago
News Placeholder
RVTY Q3 Earnings Beat, Sales In Line, '25 EPS View Raised
Revvity beats on Q3 earnings and raises 2025 EPS view, as balanced segment performance offsets margin pressure.
Zacks·24d ago

Latest RVTY News

View

Advertisement|Remove ads.

Advertisement|Remove ads.